Zoutman Willem H, Nell Rogier J, Versluis Mieke, van Steenderen Debby, Lalai Rajshri N, Out-Luiting Jacoba J, de Lange Mark J, Vermeer Maarten H, Langerak Anton W, van der Velden Pieter A
Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
J Mol Diagn. 2017 Mar;19(2):236-243. doi: 10.1016/j.jmoldx.2016.10.006. Epub 2016 Dec 22.
Quantifying T cells accurately in a variety of tissues of benign, inflammatory, or malignant origin can be of great importance in a variety of clinical applications. Flow cytometry and immunohistochemistry are considered to be gold-standard methods for T-cell quantification. However, these methods require fresh, frozen, or fixated cells and tissue of a certain quality. In addition, conventional and droplet digital PCR (ddPCR), whether followed by deep sequencing techniques, have been used to elucidate T-cell content by focusing on rearranged T-cell receptor (TCR) genes. These approaches typically target the whole TCR repertoire, thereby supplying additional information about TCR use. We alternatively developed and validated two novel generic single duplex ddPCR assays to quantify T cells accurately by measuring loss of specific germline TCR loci and compared them with flow cytometry-based quantification. These assays target sequences between the Dδ2 and Dδ3 genes (TRD locus) and Dβ1 and Jβ1.1 genes (TRB locus) that become deleted systematically early during lymphoid differentiation. Because these ddPCR assays require small amounts of DNA instead of freshly isolated, frozen, or fixated material, initially unanalyzable (scarce) specimens can be assayed from now on, supplying valuable information about T-cell content. Our ddPCR method provides a novel and sensitive way for quantifying T cells relatively fast, accurate, and independent of the cellular context.
在各种临床应用中,准确量化良性、炎症性或恶性来源的多种组织中的T细胞可能非常重要。流式细胞术和免疫组织化学被认为是T细胞定量的金标准方法。然而,这些方法需要具有一定质量的新鲜、冷冻或固定的细胞和组织。此外,传统的和液滴数字PCR(ddPCR),无论是否随后采用深度测序技术,都已被用于通过关注重排的T细胞受体(TCR)基因来阐明T细胞含量。这些方法通常针对整个TCR库,从而提供有关TCR使用的额外信息。我们另外开发并验证了两种新型通用单重ddPCR检测方法,通过测量特定种系TCR基因座的缺失来准确量化T细胞,并将它们与基于流式细胞术的定量方法进行比较。这些检测方法针对Dδ2和Dδ3基因(TRD基因座)以及Dβ1和Jβ1.1基因(TRB基因座)之间的序列,这些序列在淋巴细胞分化早期会系统性地缺失。由于这些ddPCR检测方法只需要少量DNA,而不是新鲜分离、冷冻或固定的材料,从现在起可以对最初无法分析(稀少)的样本进行检测,从而提供有关T细胞含量的有价值信息。我们的ddPCR方法提供了一种新颖且灵敏的方式,能够相对快速、准确且独立于细胞背景地定量T细胞。